The New Normal Fund
VC Fund
San Francisco, United States
The New Normal Fund is a VC fund in San Francisco focused on Artificial Intelligence and Software. The New Normal Fund is collaborating with B2B AI companies to expand to IPO and beyond.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries The New Normal Fund invests in
Stages The New Normal Fund invests in
Countries The New Normal Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Artificial Intelligence 21 (54%)
- Software 20 (51%)
- Information Technology 11 (28%)
- SaaS 6 (15%)
- Internet 5 (13%)
Stage
- Seed 12 (31%)
- Series A 11 (28%)
- Venture - Series Unknown 5 (13%)
- Series B 4 (10%)
- Pre-Seed 3 (8%)
Country
- United States 32 (82%)
- Brazil 1 (3%)
- Germany 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allison Pickens
Founder & General Partner
|
Founder & General Partner | Total investments: 60 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| On-device SDK (developer suite) for running highly optimized inference, fine-tuning, and operating LLMs and other deep learning models on the device. We aim to make it easy for developers to choose and route the query to the right model and deploy it to the device in a couple of clicks.Mirai is addressing a significant gap in on-device AIinference and training. Current cloud-based models face high latency, privacy concerns, and reliance on constant connectivity. Developers also struggle with high costs for personalization (e.g., $100M per year for 1M MAU) which is the most crucial pain point now and a core of our GTM. There’s no existing developer-friendly solution for on-device mobile AI, fine-tuning, and management. Our vision involves expanding from a robust SDK to include a developer console for model management, benchmarks, and fine-tuning. | $10M / Seed / Feb 19, 2026 | ||
| Clarify is an AI-powered writing tool that accelerates the academic writing process. | $15M / Series A / Jun 25, 2025 | ||
| Next-gen CRM, unifying customer data, automation & analytics. | Jun 25, 2025 | ||
| Next-gen CRM, unifying customer data, automation & analytics. | $15M / Series A / Jun 10, 2025 | ||
| Parable is the AI intelligence layer for enterprise operations. | $5.2M / Pre-Seed / Jul 09, 2024 | ||
| Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports. | $18M / Series A / Mar 26, 2024 | ||
| Unstructured Technologies transforms natural language data from raw to machine learning-ready. Its open-source libraries and APIs build custom preprocessing pipelines for labeling, training, or production machine learning pipelines. | $40M / Series B / Mar 14, 2024 | ||
| XBuild is an AI-powered construction platform designed to streamline various aspects of the construction process, including estimation, supplementation, permitting, closeout, and instant financing. The platform specifically caters to the construction industry's needs by offering tools for insurance-ready roofing scopes for immediate approvalsand facilitating access to payments immediately after job completion. XBuild aims to simplify the construction workflow, allowing contractors to focus on the building aspect while it handles the administrative and financial tasks. The platform also features a collection of timber construction and hybrid structural solutions for inspiration and practical application. | Venture - Series Unknown / Feb 28, 2024 | ||
| Unkey operates as an open-source API authentication and authorization platform, primarily catering to user-facing APIs. The platform enables developers to create, verify, and manage API keys with low latency. Unkey's services are designed to help developers secure, manage, and scale their APIs. The company also offers an Elixir SDK, providinga simple example of its use. Unkey is also involved in solving API authentication for the next generation of developers. | $1.6M / Pre-Seed / Nov 15, 2023 | ||
| Norm Ai provides solutions for sludge problem by enabling compliance teams to delegate tasks to Regulatory AI via high-level instructions, while at the same time validating the resulting work product. | Venture - Series Unknown / Oct 26, 2023 | ||
| See all 39 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does The New Normal Fund invest in?
The New Normal Fund invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact The New Normal Fund?
Public channels for The New Normal Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The New Normal Fund?
The team at The New Normal Fund includes Allison Pickens (Founder & General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
